Medicare Enrolled
Dr. Luis Rodriguez, M.D.
Medical Oncology · San Antonio, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rodriguez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rodriguez?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rodriguez
Dr. Luis Rodriguez is a medical oncology specialist in San Antonio, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rodriguez performed 12,671 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Rodriguez received a total of $19,744 from 68 pharmaceutical and/or device companies across 485 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rodriguez is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 39% volume in TX
$19,744 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗12,671
Medicare services
Top 39% in TX for medical oncology
Not available
Unique patients (not deduplicated)
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 8,220 | $18 | $71 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
970 | $0 | $0 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
486 | $8 | $23 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
420 | $8 | $15 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
419 | $10 | $32 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
296 | $89 | $373 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
275 | $63 | $264 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
218 | $21 | $86 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
158 | $95 | $376 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
127 | $11 | $47 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
123 | $6 | $18 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
101 | $46 | $205 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
82 | $11 | $58 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
71 | $6 | $19 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
70 | $13 | $41 |
| Iron level test | 68 | $6 | $19 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
68 | $9 | $26 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 58 | $329 | $1,404 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
49 | $22 | $90 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
46 | $19 | $57 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
46 | $133 | $523 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
45 | $62 | $232 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
39 | $49 | $184 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
37 | $6 | $20 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
35 | $9 | $28 |
| New patient office visit, complex (60-74 min) | 35 | $167 | $641 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
24 | $39 | $145 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
22 | $8 | $25 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
22 | $117 | $486 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
21 | $93 | $349 |
| Liver function blood test panel | 20 | $8 | $25 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.1% high complexity
75.0% medium
20.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,744
Total received (2018-2024)
Avg $2,821/year across 7 years
Top 30% in TX for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
68
Companies
485
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,566
2023
$2,548
2022
$1,920
2021
$819
2020
$2,090
2019
$2,382
2018
$6,418
Payments by company (2024)
E.R. Squibb & Sons, L.L.C.
$380
Janssen Biotech, Inc.
$355
AstraZeneca Pharmaceuticals LP
$340
Regeneron Healthcare Solutions, Inc.
$314
Tempus AI, Inc
$236
Gilead Sciences, Inc.
$228
Novartis Pharmaceuticals Corporation
$147
Takeda Pharmaceuticals U.S.A., Inc.
$146
Daiichi Sankyo Inc.
$139
PFIZER INC.
$132
BeiGene USA, Inc.
$125
Adaptive Biotechnologies Corporation
$124
Lilly USA, LLC
$123
Merck Sharp & Dohme LLC
$108
PharmaEssentia USA Corporation
$88
SOBI, INC
$63
Karyopharm Therapeutics Inc.
$61
Genentech USA, Inc.
$48
GENZYME CORPORATION
$42
Incyte Corporation
$41
GlaxoSmithKline, LLC.
$40
Eisai Inc.
$40
SANOFI PASTEUR INC.
$26
Bayer Healthcare Pharmaceuticals Inc.
$24
Spectrum Pharmaceuticals Inc.
$23
ABBVIE INC.
$23
Coherus Biosciences Inc.
$22
EMD Serono, Inc.
$19
PUMA BIOTECHNOLOGY, INC.
$18
ADC Therapeutics America, Inc.
$17
Acrotech Biopharma Inc.
$16
Genmab U.S., Inc.
$16
Geron Corporation
$15
SERVIER PHARMACEUTICALS LLC
$15
Agios Pharmaceuticals, Inc.
$13
Top 3 companies account for 30.1% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,972
E.R. Squibb & Sons, L.L.C.
$2,914
AstraZeneca UK Limited
$2,359
Janssen Biotech, Inc.
$1,181
Genentech USA, Inc.
$873
Novartis Pharmaceuticals Corporation
$665
Amgen Inc.
$606
Regeneron Healthcare Solutions, Inc.
$595
Adaptive Biotechnologies Corporation
$543
Lilly USA, LLC
$451
PFIZER INC.
$437
Karyopharm Therapeutics Inc.
$364
GlaxoSmithKline, LLC.
$319
Daiichi Sankyo Inc.
$319
Eisai Inc.
$318
Takeda Pharmaceuticals U.S.A., Inc.
$302
Gilead Sciences, Inc.
$289
Kite Pharma, Inc.
$274
Puma Biotechnology, Inc.
$267
BeiGene USA, Inc.
$250
GENZYME CORPORATION
$241
Tempus AI, Inc
$236
Exelixis Inc.
$218
Merck Sharp & Dohme LLC
$215
Seagen Inc.
$181
Ipsen Biopharmaceuticals, Inc
$172
AbbVie, Inc.
$159
Coherus Biosciences Inc.
$147
Incyte Corporation
$146
LivaNova USA, Inc.
$135
PharmaEssentia USA Corporation
$109
ADC Therapeutics America, Inc.
$95
Astellas Pharma US Inc
$91
Celgene Corporation
$90
AVEO Pharmaceuticals, Inc.
$83
Taiho Oncology, Inc.
$80
Merck Sharp & Dohme Corporation
$79
SERVIER PHARMACEUTICALS LLC
$70
SOBI, INC
$63
Bayer Healthcare Pharmaceuticals Inc.
$59
Mirati Therapeutics, Inc.
$54
Pharmacyclics LLC, An AbbVie Company
$46
TAIHO ONCOLOGY, INC.
$45
EISAI INC.
$42
PUMA BIOTECHNOLOGY, INC.
$40
Genmab U.S., Inc.
$39
MorphoSys, US Inc.
$38
Janssen Pharmaceuticals, Inc
$36
EMD Serono, Inc.
$35
Kyowa Kirin, Inc.
$35
AbbVie Inc.
$34
Medtronic USA, Inc.
$28
Helsinn Therapeutics (U.S.), Inc.
$27
SANOFI PASTEUR INC.
$26
Seattle Genetics, Inc.
$23
Spectrum Pharmaceuticals Inc.
$23
ABBVIE INC.
$23
Rigel Pharmaceuticals, Inc.
$22
Alexion Pharmaceuticals, Inc.
$22
Blueprint Medicines Corporation
$19
CTI BioPharma Corp.
$18
Acrotech Biopharma Inc.
$16
Sanofi Pasteur Inc.
$16
Geron Corporation
$15
Amneal Pharmaceuticals LLC
$15
Bayer HealthCare Pharmaceuticals Inc.
$14
Agios Pharmaceuticals, Inc.
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Top 3 companies account for 41.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Avastin · BALVERSA · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRUKINSA · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Epkinly · Erleada · FARESTON · FOTIVDA · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Gazyva · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MENACTRA · MENQUADFI · MONJUVI · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · OJJAARA · OPDIVO · OPDUALAG · Onivyde · PADCEV · PIQRAY · POLIVY · POTELIGEO · PROMACTA · PYRUKYND · Perjeta · Pomalyst · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · RYDAPT · RYTELO · Revlimid · Rezlidhia · Rituxan · Rituxan Hycela · SANDOSTATIN · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYNCHROMED · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tibsovo · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VNS Therapy · VOTRIENT · Vanflyta · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Yescarta · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
38
County median income
$70,571
Nearest hospital to ZIP centroid (approximate)
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rodriguez is a mixed practice specialist, with moderate Medicare volume, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rodriguez experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Rodriguez performed 8,220 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Rodriguez receive payments from pharmaceutical companies?
Yes. Dr. Rodriguez received a total of $19,744 from 68 companies across 485 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rodriguez's costs compare to other medical oncologists in San Antonio?
Dr. Rodriguez's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rodriguez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in San Antonio
Browse medical oncologists in San Antonio ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in TX
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in TX
Which TX medical oncologists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
AstraZeneca UK Limited Payments to Doctors
See all physicians who received payments from AstraZeneca UK Limited.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology